Jennifer J Rhodes Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer J Rhodes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer J Rhodes. Jennifer J Rhodes is a GC & Chief Compliance Officer in MEDIVATION, INC. ($MDVN) and a GC & Corporate Secretary in MEDIVATION, INC. ($MDVN) and a CBO, GC & Compliance Officer in Adamas Pharmaceuticals Inc ($ADMS) and a General Counsel in Adamas Pharmaceuticals Inc ($ADMS) and a See Remarks in Angion Biomedica Corp. ($ANG).
Address: C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO 94105 CA
Companies in which Jennifer J Rhodes is an Insider
Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer J Rhodes: CBO, GC & Compliance Officer, General Counsel
Holdings: 63,114 shares
Current Value: $1,019,922
Latest Transaction: Jun 21 2019
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Angion Biomedica Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer J Rhodes: See Remarks
Holdings: 33,887 shares
Latest Transaction: Apr 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer J Rhodes: GC & Corporate Secretary, GC & Chief Compliance Officer
Holdings: 11,090 shares
Latest Transaction: Mar 17 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jennifer J Rhodes
Sentiment: All, ADMS, ANG, MDVN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 15.01 | 399 | 5,989 | 33,887 | 34.3 K to 33.9 K (-1.16 %) |
| Mar 16 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 20.45 | 499 | 10,205 | 34,286 | 34.8 K to 34.3 K (-1.43 %) |
| Feb 17 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Sell | S | 19.54 | 457 | 8,930 | 34,785 | 35.2 K to 34.8 K (-1.30 %) |
| Feb 08 2021 | ANG | Angion Biomedica C ... | Rhodes Jennifer J | See Remarks | Option Exercise | A | 16.00 | 70,012 | 1,120,192 | 70,012 | |
| Jun 21 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Sell | S | 5.35 | 940 | 5,029 | 63,114 | 64.1 K to 63.1 K (-1.47 %) |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Option Exercise | A | 6.81 | 60,000 | 408,600 | 60,000 | |
| Apr 10 2019 | ADMS | Adamas Pharmaceuti ... | Rhodes Jennifer J | CBO, GC & Complianc ... | Grant | A | 0.00 | 30,000 | 0 | 61,612 | 31.6 K to 61.6 K (+94.90 %) |